Communicating about Drugs

Scientific and Technical Communication: A Pressing National Problem and Recommendations for Its Solution, A Report by The Committee on Scientific and Technical Communication of the National Academy of Sciences - National Academy of Engineering, National Academy of Sciences, Washington, D.C., 1969.

Proceedings of the International Conference on Scientific Information, National Science Foundation, National Academy of Sciences - National Research Council, and American Documentation Institute. National Academy of Sciences - National Research Council, Washington, D.C., 1959.

Science, Government, and Information: The Responsibilities of the Technical Community and the Government in the Transfer of Information, A Report of the President's Science Advisory Committee. Government Printing Office, Washington, D.C., Jan. 10, 1963.

Improving the Availability of Scientific and Technical Information in the United States, A Report of The President's Science Advisory Committee. The White House Washington, D.C., Dec. 7, 1958.

The Royal Society: Scientific Information Conference, 2 vols., Burlington House, London, 1948.

Sadusk J.F. Jr. : Reflections Upon Biomedical Communications, Drug Inf. Bull. 1:5–6, Oct.-Dec. 1966.

Sarett L.H. : The Scientist and Scientific Data, Am. Doc. 19:301, July 1968.

U.S. President: Public Papers of the Presidents of the United States, Office of the Federal Register, National Archives and Records Service, Washington, D.C., 1962, J.F. Kennedy, Feb. 27, 1962, p. 169.

Terry L.L. : Paper presented at the Midyear Conference for Presidents and Secretaries of the Allied Hospital Associations, Chicago, Jan. 31, 1963, p. 2.

Task Force on Prescription Drugs: The Drug Makers and The Drug Distributors: Background Papers, U.S. Dep. Health, Education, and Welfare, Office of the Secretary. Government Printing Office, Washington, D.C., Dec. 1968, p. 20.

Task Force on Prescription Drugs: The Drug Prescribers: Background Papers, U.S. Dep. Health, Education, and Welfare, Office of the Secretary Government Printing Office, Washington, D.C., Dec. 1968, p. 9.

Reilly M.J. : Drug Information: Literature Review of Needs, Resources, and Services, Case Study Series Pub. No. (HSM) 72–3013, U.S. Dep. Health, Education, and Welfare, Health Services and Mental Health Administration, National Center for Health Services Research and Development. Washington, D.C., March 1972, pp. 10–60.

National Library of Medicine: A Factual Survey on “The Nature and Magnitude of Drug Literature,” report prepared for the Study of “Interagency Coordination in Drug Research and Regulation” by the Subcommittee on Reorganization and International Organizations of the Senate Committee on Government Operations. Government Printing Office, Washington, D.C., Aug. 30, 1963, pp. 8–31.

Task Force on Prescription Drugs: Final Report, U.S. Dep. Health, Education, and Welfare, Office of the Secretary. Government Printing Office, Washington, D.C., Feb. 7, 1969, p. 21.

Brodie D.C. : Drug Utilization and Drug Utilization Review and Control, Pub. No. (HSM) 72–3002, U.S. Dep. Health, Education, and Welfare, Health Services and Mental Health Administration, National Center for Health Services Research and Development, Washington, D.C., May 1971, p. 2.

Anonymous: How to Improve Drug Prescribing Discussed at Kennedy Hearing, PMA Newsletter 16:2, March 1974.

Caranasos G.J. Stewart R.B. Cluff L.E. : Drug Induced Illness Leading to Hospitalization, JAMA 228:713, May 6, 1974.

Seidl L.G. Thornton G.F. Smith J.W. Cluff L.E. : Studies on the Epidemiology of Adverse Drug Reactions: III. Reactions in Patients on a General Medical Service, Bull. Johns Hopkins Hosp. 119:301, 304, 1966.

Cluff L.E. : Problems with Drugs, In: Proceedings of a Conference on Continuing Education for Physicians in the Use of Drugs. National Academy of Sciences - National Research Council, Food and Drug Administration, Health Services and Mental Health Administration, Washington, D.C., Feb. 5, 1969, p. 10.

Jick H. : Drugs - Remarkably Nontoxic, N. Engl. J. Med. 291:824–827, Oct. 17, 1974.

Karch F. Lasagna L. : Adverse Drug Reactions in the United States: An Analysis of the Scope of the Problem and Recommendations for Future Approaches, Medicine in the Public Interest, Washington, D.C., n.d.

Stetler C.J. : Statement before the Subcommittee on Health of the Senate Committee on Labor and Public Welfare, May 21, 1974, p. 6.

Simmons H.E. : Closing the Communications Gap: FDA's Drug Bulletin, FDA Papers 6:6, March 1972.

Walton C.A. : Scope and Content of a Course in Drug Literature Evaluation, Am. J. Pharm. Educ. 32:853, Dec. 1968.